The Pipeline Flex embolization device, which received CE Mark approval in earlier 2014, has been designed to divert blood flow away from an aneurysm. The minimally-invasive device cuts off blood flow to the aneurysm, reconstructing the diseased section of the parent vessel.
Pipeline Flex flow diversion device incorporates a braided cylindrical mesh tube that is implanted across the base or neck of the aneurysm. Covidien has designed the Pipeline Flex device for more accuracy and controlled placement.
The next-generation flow diversion device is repositionable and features instant braid release system, which makes it even easier to place. The Pipeline Flex device is not currently approved for use in the US.
Covidien Neurovascular president Brett Wall said: "The Pipeline Flex embolization device is the next advancement in flow diversion, combining our clinically-proven braid design2 with a new delivery system designed to offer even more accuracy and control when performing these advanced procedures inside the brain."
Covidien’s first-generation Pipeline embolization device has been used to treat patients in Europe since 2009. The device received approval from the US Food and Drug Administration in April 2011.
Image: Covidien’s Pipeline Flex embolization device is the next advancement in flow diversion in Europe. Photo: Courtesy of Business Wire/ Covidien plc
